Smart Report
Patient Name : KOTTAI MUTHU Sample Collection : 2024-11-14T07:57:08
Age/Gender : 74 Years/Male Date
UHID : AC01.0004085936 Mobile Number : --
Location : -- Blood Group : --
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
Lab Report Summary
Heart
Glands & Endocrine System
5 Parameters
2 Parameters
kidney
2 Parameters
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
System Wise Lab Tests
Heart
TRIGLYCERIDES NON-HDL CHOLESTEROL
LDL CHOLESTEROL VLDL CHOLESTEROL
CHOL / HDL RATIO
kidney
UREA CREATININE
Glands & Endocrine System
GLUCOSE, FASTING GLUCOSE, POST PRANDIAL (PP), 2 HOURS
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
GLUCOSE, FASTING
Fasting Glucose is the measurement of levels of blood glucose after fasting/not consuming food for 10-12 hours
GLUCOSE, FASTING 340 mg/dL 70 - 100 mg/dL
70.0 100.0 126.0
Info- Fasting Glucose when abnormal is divided into ranges - Prediabetic and Diabetic. Inference- Your Sugar Levels are in Diabetic Range
Prediabetic Ranges can usually be managed using lifestyle changes
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
HBA1C, GLYCATED HEMOGLOBIN
The HBA1C test measures the average blood sugar level over the past 3 months. This test helps in evaluating the long-term control of blood glucose concentrations in
patients with diabetes
HBA1C, GLYCATED HEMOGLOBIN ESTIMATED AVERAGE GLUCOSE (eAG)
10.8 % 263 mg/dL
Info- HBA1C indicates the range of glucose that was in your blood for the past few Info- Estimated Average Glucose Eag are h type concentrations white helps cells which pati
months past majportion concentrations past immues response
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
GLUCOSE, POST PRANDIAL (PP), 2 HOURS (POST MEAL)
The Post prandial test measures the level of glucose in your blood two hours post meal.
GLUCOSE, POST PRANDIAL (PP), 2 HOURS 565 mg/dL 70 - 140 mg/dL
70.0 140.0 200.0
Info- The postprandial glucose blood sugar test is primarily used to test for and diagnose Inference- Your Sugar Levels are in Diabetic Range
Type 1, Type 2, and gestational diabetes.
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
UREA - SERUM
UREA 26.1 mg/dL 19.26 - 42.8 mg/dL
19.3 42.8
Info- Blood Urea Nitrogen test is to measure the Nitrogren levels in your blood that signify the levels of waste products in your blood
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
CREATININE, SERUM
CREATININE 0.8 mg/dL 0.5 - 1.04 mg/dL
0.5 0.5 1.0
Info- Creatinine is another waste product formed when your muscles use a compound called creatine to produce energy
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
LIPID PROFILE
The different kinds of cholesterol and other fats in the blood are together called lipids. A Lipid profile gives results for four different types which is Total Cholesterol, LDL -
Bad cholesterol HDL - Good Cholesterol and Triglycerides - Common type of fat in the body
TOTAL CHOLESTEROL HDL CHOLESTEROL
169 mg/dL 60 mg/dL
Info- Total Amount of all types of Cholestrol in your body Info- HDL Cholesterol is also referred to as the "Good Cholesterol"
TRIGLYCERIDES 78 mg/dL 0 - 150 mg/dL
0.0 150.0 200.0
Info- Triglycerides are a type of fats present in your body
NON-HDL CHOLESTEROL 108 mg/dL 0 - 130 mg/dL
0.0 130.0
Info- As HDL Cholestrol is defined as the good cholestrol the other forms of cholestrol that are harmful to your body are included in this parameter
LDL CHOLESTEROL 92.74 mg/dL 0 - 100 mg/dL
0.0 100.0
Info- LDL Cholesterol is also referred to as the "Bad Cholesterol"
VLDL CHOLESTEROL 15.66 mg/dL 5 - 30 mg/dL
5.0 30.0
Info- VLDL Cholesterol i.e Very-low-density protein produced in the liver
CHOL / HDL RATIO 2.8 0 - 4.97
0.0 5.0
Info- Cholesterol - HDL Ratio depicts the Good vs bad cholesterol ratio in your body. Higher the value, higher the risk of complications
ATHEROGENIC INDEX (AIP) 0.1 0 - 0.11
0.0 0.1
Patient Info
UHID Patient Name Age & Gender Sample Collection Time
AC01.0004085936 KOTTAI MUTHU 74 Years / Male 11/14/2024, 7:57:08 AM
Recommendations
Test Recommendations
Follow Up Recommendation
HBA1C
Speciality Recommendations
Follow Up Recommendation Other Recommendations
General Medicine Endocrinalogist/diabatologist
Note:Follow up tests are recommended based on laboratory report analysis, please reach to your doctor to seek advice regarding the following additional tests.
Disclaimer :
This report is for educating patients (especially in diet & lifestyle).
This report is not intended to replace your clinicians, we recommend to contact your clinicians for interpretation of result.
If you are pregnant, some of the recommendations in the Smart Report may not directly apply to you. Please consult your doctor.
The analyzed information in the Smart Report is not ideal for individuals less than 15 years of age. Please make sure you consult your doctor before further actions.
Please be careful of any food allergies or intolerances that you are sensitive to.
Patient Name : [Link] MUTHU Collected : 14/Nov/2024 10:16AM
Age/Gender : 75 Y 0 M 0 D /M Received : 14/Nov/2024 12:50PM
UHID/MR No : AC01.0004085936 Reported : 14/Nov/2024 03:33PM
Visit ID : DSHOOPV29451 Status : Final Report
Ref Doctor : [Link] Client Name : PCC SHOLINGANALLUR CHENNAI
IP/OP NO : Center location : Sholinganallur,Chennai
DEPARTMENT OF BIOCHEMISTRY
XPERT HEALTH DIABETES & LIPID PROFILE
Test Name Result Unit Bio. Ref. Interval Method
GLUCOSE, FASTING , NAF PLASMA 340 mg/dL 70-100 GOD - POD
Comment:
As per American Diabetes Guidelines, 2023
Fasting Glucose Values in mg/dL Interpretation
70-100 mg/dL Normal
100-125 mg/dL Prediabetes
≥126 mg/dL Diabetes
<70 mg/dL Hypoglycemia
Note:
[Link] diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL and/or a random / 2 hr post glucose value of
> or = 200 mg/dL on at least 2 occasions.
2. Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis & is considered critical.
Test Name Result Unit Bio. Ref. Interval Method
GLUCOSE, POST PRANDIAL (PP), 2 565 mg/dL 70-140 GOD - POD
HOURS , SODIUM FLUORIDE PLASMA
(2 HR)
Result is rechecked. Kindly correlate clinically
Comment:
It is recommended that FBS and PPBS should be interpreted with respect to their Biological reference ranges and not with each
other.
Conditions which may lead to lower postprandial glucose levels as compared to fasting glucose levels may be due to reactive
hypoglycemia, dietary meal content, duration or timing of sampling after food digestion and absorption, medications such as insulin
preparations, sulfonylureas, amylin analogues, or conditions such as overproduction of insulin.
Page 1 of 4
SIN No:BI22711201
Patient Name : [Link] MUTHU Collected : 14/Nov/2024 07:57AM
Age/Gender : 75 Y 0 M 0 D /M Received : 14/Nov/2024 01:35PM
UHID/MR No : AC01.0004085936 Reported : 14/Nov/2024 02:15PM
Visit ID : DSHOOPV29451 Status : Final Report
Ref Doctor : [Link] Client Name : PCC SHOLINGANALLUR CHENNAI
IP/OP NO : Center location : Sholinganallur,Chennai
DEPARTMENT OF BIOCHEMISTRY
XPERT HEALTH DIABETES & LIPID PROFILE
Test Name Result Unit Bio. Ref. Interval Method
HBA1C (GLYCATED HEMOGLOBIN) , WHOLE BLOOD EDTA
HBA1C, GLYCATED HEMOGLOBIN 10.8 % HPLC
ESTIMATED AVERAGE GLUCOSE 263 mg/dL Calculated
(eAG)
Comment:
Reference Range as per American Diabetes Association (ADA) 2023 Guidelines:
REFERENCE GROUP HBA1C %
NON DIABETIC <5.7
PREDIABETES 5.7 – 6.4
DIABETES ≥ 6.5
DIABETICS
EXCELLENT CONTROL 6–7
FAIR TO GOOD CONTROL 7–8
UNSATISFACTORY CONTROL 8 – 10
POOR CONTROL >10
Note: Dietary preparation or fasting is not required.
1. HbA1C is recommended by American Diabetes Association for Diagnosing Diabetes and monitoring Glycemic
Control by American Diabetes Association guidelines 2023.
2. Trends in HbA1C values is a better indicator of Glycemic control than a single test.
3. Low HbA1C in Non-Diabetic patients are associated with Anemia (Iron Deficiency/Hemolytic), Liver Disorders, Chronic Kidney Disease. Clinical Correlation is
advised in interpretation of low Values.
4. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or decrease mean erythrocyte age. HbA1c may
not accurately reflect glycemic control when clinical conditions that affect erythrocyte survival are present.
5. In cases of Interference of Hemoglobin variants in HbA1C, alternative methods (Fructosamine) estimation is recommended for Glycemic Control
A: HbF >25%
B: Homozygous Hemoglobinopathy.
(Hb Electrophoresis is recommended method for detection of Hemoglobinopathy)
Page 2 of 4
SIN No:BI22711200
This test has been performed at Apollo Health and Lifestyle Ltd - Chennai, Diagnostics Laboratory.
Patient Name : [Link] MUTHU Collected : 14/Nov/2024 07:57AM
Age/Gender : 75 Y 0 M 0 D /M Received : 14/Nov/2024 12:50PM
UHID/MR No : AC01.0004085936 Reported : 14/Nov/2024 02:54PM
Visit ID : DSHOOPV29451 Status : Final Report
Ref Doctor : [Link] Client Name : PCC SHOLINGANALLUR CHENNAI
IP/OP NO : Center location : Sholinganallur,Chennai
DEPARTMENT OF BIOCHEMISTRY
XPERT HEALTH DIABETES & LIPID PROFILE
Test Name Result Unit Bio. Ref. Interval Method
LIPID PROFILE , SERUM
TOTAL CHOLESTEROL 169 mg/dL <200 CHE/CHO/POD
TRIGLYCERIDES 78 mg/dL <150 Enzymatic
HDL CHOLESTEROL 60 mg/dL >40 CHE/CHO/POD
NON-HDL CHOLESTEROL 108 mg/dL <130 Calculated
LDL CHOLESTEROL 92.74 mg/dL <100 Calculated
VLDL CHOLESTEROL 15.66 mg/dL <30 Calculated
CHOL / HDL RATIO 2.80 0-4.97 Calculated
ATHEROGENIC INDEX (AIP) 0.10 <0.11 Calculated
Comment:
Reference Interval as per National Cholesterol Education Program (NCEP) Adult Treatment Panel III Report.
Desirable Borderline High High Very High
TOTAL CHOLESTEROL < 200 200 - 239 ≥ 240
TRIGLYCERIDES <150 150 - 199 200 - 499 ≥ 500
Optimal < 100
LDL 130 - 159 160 - 189 ≥ 190
Near Optimal 100-129
HDL ≥ 60
Optimal <130;
NON-HDL CHOLESTEROL 160-189 190-219 >220
Above Optimal 130-159
Page 3 of 4
SIN No:BI22711202
Patient Name : [Link] MUTHU Collected : 14/Nov/2024 07:57AM
Age/Gender : 75 Y 0 M 0 D /M Received : 14/Nov/2024 12:50PM
UHID/MR No : AC01.0004085936 Reported : 14/Nov/2024 03:33PM
Visit ID : DSHOOPV29451 Status : Final Report
Ref Doctor : [Link] Client Name : PCC SHOLINGANALLUR CHENNAI
IP/OP NO : Center location : Sholinganallur,Chennai
DEPARTMENT OF BIOCHEMISTRY
XPERT HEALTH DIABETES & LIPID PROFILE
Test Name Result Unit Bio. Ref. Interval Method
UREA , SERUM 26.10 mg/dL 19-43 Urease
Test Name Result Unit Bio. Ref. Interval Method
CREATININE , SERUM 0.80 mg/dL 0.5-1.04 Creatinine
amidohydrolase
*** End Of Report ***
Page 4 of 4
SIN No:BI22711202
Patient Name : [Link] MUTHU Collected : 14/Nov/2024 07:57AM
Age/Gender : 75 Y 0 M 0 D /M Received : 14/Nov/2024 12:50PM
UHID/MR No : AC01.0004085936 Reported : 14/Nov/2024 03:33PM
Visit ID : DSHOOPV29451 Status : Final Report
Ref Doctor : [Link] Client Name : PCC SHOLINGANALLUR CHENNAI
IP/OP NO : Center location : Sholinganallur,Chennai
TERMS AND CONDITIONS GOVERNING THIS REPORT
1. Reported results are for information and interpretation of the referring doctor or such other medical professionals,
who understandreporting units, reference ranges and limitation of [Link] not be responsible for any
interpretation whatsoever.
2. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the
verifications of parrticulars have been confirmed by the patient or his / her representative at the point of generation of said specimen.
3. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
4. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies.
5. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
6. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only.
SIN No:BI22711202